Edition:
United States

People: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,462.31GBp
9:21am EST
Change (% chg)

0.00p (+0.00%)
Prev Close
1,462.50p
Open
1,465.50p
Day's High
1,470.00p
Day's Low
1,458.00p
Volume
3,938,015
Avg. Vol
9,191,389
52-wk High
1,745.56p
52-wk Low
1,259.32p

Walmsley, Emma 

Ms. Emma Walmsley has been appointed as Chief Executive Officer - Designate, Director of GlaxoSmithKline PLC, effective 1 January 2017. After joining GSK in May 2010 as President of Consumer Healthcare Europe. Under Emma’s leadership the business has a new strategic direction to become the first and best Fast Moving Consumer Healthcare company, driven by science and values, combining the very best of GSK’s scientific knowledge with the speed and marketing excellence of the Fast Moving Consumer Goods world. Prior to joining GSK, Emma worked with L’Oreal for 17 years where she held a variety of marketing and general management roles in Paris, London and New York. From 2007 she was based in Shanghai as General Manager, Consumer Products, L’Oreal China. She has a degree in Classics and Modern Languages from Oxford University. Prior to this, Emma was President of GSK Consumer Healthcare and has been a member of GSK's Corporate Executive Team since 2011. Emma joined GSK in 2010 from L'Oreal where, over the course of her 17-year career, she held a variety of marketing and general management roles in the UK, Europe and USA. From 2007 she was based in Shanghai as General Manager, Consumer Products for L'Oreal China.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Philip Hampton

522,000

Andrew Witty

6,661,000

Simon Dingemans

3,166,000

Moncef Slaoui

7,324,000

Roger Connor

--

Abbas Hussain

--
As Of  30 Dec 2015